5.23 USD
↗ 0.04 (0.77%)LIVE (AS OF 11:34 AM EDT)
Champions Oncology, Inc.
CSBRNASDAQ • USD
Market: OPEN
Champions Oncology, Inc. (CSBR) is currently trading at $5.23. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CSBR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 6, 2026.
Open?$5.20
High?$5.30
Low?$5.09
Prev. Close?$5.19
Volume?455
Avg. Volume?9.5K
VWAP?$5.19
Rel. Volume?0.05x
Bid / Ask
Bid?$4.30 × 100
Ask?$6.14 × 100
Spread?$1.84
Midpoint?$5.22
Valuation & Ratios
Market Cap?72.1M
Shares Out?13.9M
Float?5.1M
Float %?36.4%
P/E Ratio?N/A
P/B Ratio?18.31
EPS?-$0.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Themes
Employees
214
Market Cap
73.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1994-10-31
Address
855 N. WOLFE STREET
BALTIMORE, MD 21205
Phone: 410-369-0365
BALTIMORE, MD 21205
Phone: 410-369-0365
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?2
Momentum?79
Short Sent.?51
Piotroski F-Score?4/9Mixed
Altman Z-Score?-0.23Distress
Confidence?48%Low
Short InterestHigh
Short % of Float?1.50%Low
Short Interest?75.6K
Days to Cover?7.9
Free Float5.1M
Avg Daily Volume9.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.96Weak
Quick Ratio?0.96Weak
Cash Ratio?0.24Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?18.31HIGH▾
Peers100
S&P8
P/S?1.21CHEAP▾
Peers100
S&P83
P/FCF?N/A▾
EV/EBITDA?193.8HIGH▾
Peers100
S&P3
EV/Sales?1.13CHEAP▾
Peers100
S&P90
Returns & Efficiency
ROE?-28.3%WEAK▾
S&P6
ROA?-4.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-5036000
Enterprise Value?$67.2M
Fundamentals ratios updated end of day